Takako H.

Project Manager (Safety) for Investigator-initiated Trials at National Cancer Center Hospital
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
JP
Languages
  • 日本語 -
  • English -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Public Health Nurse
    Japan Ministry of Health, Labour and Welfare
    Mar, 2003
    - Oct, 2024
  • Registered Nurse
    Japan Ministry of Health, Labour and Welfare
    Mar, 2003
    - Oct, 2024

Experience

    • Japan
    • Hospitals and Health Care
    • 100 - 200 Employee
    • Project Manager (Safety) for Investigator-initiated Trials
      • May 2019 - Present

  • Japan Healthcare Data
    • Greater New York City Area
    • Director of Data Services
      • Oct 2015 - Jan 2019

      As a part of consulting firm which provides data-driven strategy to world's leading healthcare/pharmaceutical/medical device companies, I collected Japan's healthcare market data from reliable statistical survey results, translated them from Japanese to English, and made reports to be used in presentation to customers. As a part of consulting firm which provides data-driven strategy to world's leading healthcare/pharmaceutical/medical device companies, I collected Japan's healthcare market data from reliable statistical survey results, translated them from Japanese to English, and made reports to be used in presentation to customers.

  • Baxter Japan
    • Within 23 wards, Tokyo, Japan
    • Senior Pharmacovigilance Specialist
      • Mar 2010 - Feb 2015

      As a member of drug safety group, I reported individual adverse event cases and periodical reports to PMDA, supervised other members' reporting, managed a post marketing surveillance, and conducted an early post-marketing phase vigilance. The drugs included fluids, bioscience products and anesthetic agents. As a member of drug safety group, I reported individual adverse event cases and periodical reports to PMDA, supervised other members' reporting, managed a post marketing surveillance, and conducted an early post-marketing phase vigilance. The drugs included fluids, bioscience products and anesthetic agents.

    • Clinical Research Coordinator
      • Apr 2007 - Feb 2010

      I worked on several phase I, IIb, and III clinical trials (mostly phase I studies) at some hospitals and a clinic within 23 wards of Tokyo and one hospital Kanagawa prefecture. The investigational products included cardiovascular, gastroenterological and gynecologic agents. I worked on several phase I, IIb, and III clinical trials (mostly phase I studies) at some hospitals and a clinic within 23 wards of Tokyo and one hospital Kanagawa prefecture. The investigational products included cardiovascular, gastroenterological and gynecologic agents.

    • Hospitals and Health Care
    • 1 - 100 Employee
    • Registered Nurse
      • Apr 2003 - Mar 2005

      As a nurse working at the hematology ward with a transplantation unit, I took care of patients with leukemia, lymphoma, myeloma, anemia, etc. The patients were undergoing chemotherapy, radiotherapy, or blood stem cell/bone marrow transplantation. As a nurse working at the hematology ward with a transplantation unit, I took care of patients with leukemia, lymphoma, myeloma, anemia, etc. The patients were undergoing chemotherapy, radiotherapy, or blood stem cell/bone marrow transplantation.

Education

  • Graduate School of Medicine, The University of Tokyo
    Master of Health Sciences, Adult Health Nurse/Nursing
    2003 - 2007
  • 東京大学
    Bachelor of Health Sciences, Health Sciences and Nursing
    1999 - 2003

Community

You need to have a working account to view this content. Click here to join now